Table 1.
Characteristics of 8880 patients transplanted for hepatocellular carcinoma (1987–2012)
| Age, years, median (IQR) | 57 (53–62) |
| MELD score, median (IQR) | 13 (9–18) |
| BMI, median (IQR) | 27.8 (24.8–31.5) |
| Gender, n (%) | |
| Female | 1931 (22%) |
| Male | 6949 (78%) |
| Race, n (%) | |
| White | 5777 (65%) |
| African-American | 765 (9%) |
| Asian | 779 (9%) |
| Hispanic | 1436 (16%) |
| Other | 123 (1%) |
| Cirrhosis, n (%) | |
| No | 2347 (26%) |
| Yes | 6533 (74%) |
| Diabetes, n (%) | |
| No | 6339 (71%) |
| Yes | 2422 (27%) |
| Unknown | 119 (0.01%) |
| Viral status, n (%) | |
| HBV−/HCV− | 2530 (28%) |
| HBV+/HCV− | 629 (7%) |
| HBV−/HCV+ | 5552 (62%) |
| HBV+/HCV+ | 169 (2%) |
| Era, n (%) | |
| Pre-2000 | 482 (5%) |
| 2000–2004 | 1338 (15%) |
| 2005–2012 | 7060 (80%) |
IQR, interquartile range; MELD, Model for End-stage Liver Disease; BMI, body mass index; HBV, hepatitis B virus; HCV, hepatitis C virus.